- Tolerance induction, transplantation, dendritic cells, genetic engineering
- Tolerance induction with dendritic cells
- Daclizimab dosing strategy in kidney/pancreas transplant recipients
Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation.
J Hepatol. 2019 Jan 07;:
Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.
J Hepatol. 2019 Jan 04;:
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Liver Transpl. 2019 Jan;25(1):56-67
Live Donor Liver Transplantation Using selected Grafts with Two Bile Ducts compared to One Bile Duct Does not Impact on Patient Outcome.
Liver Transpl. 2018 Sep 28;:
Splenectomy as Flow Modulation Strategy and Risk Factors of De-novo Portal Vein Thrombosis in Adult-to-Adult Living Donor Liver Transplant.
Liver Transpl. 2018 Aug 26;:
Infect Control Hosp Epidemiol. 2018 Jul 13;:1-7
Tumor Dendritic Cells (DCs) Derived from Precursors of Conventional DCs Are Dispensable for Intratumor CTL Responses.
J Immunol. 2018 Jul 11;:
Live Donor Liver Transplantation With Older Donors: Increased Long-Term Graft Loss Due to HCV Recurrence.
Clin Transplant. 2018 Jun 26;:e13304
Transplant Direct. 2018 May;4(5):e348
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Professor, Department of Surgery, University of Toronto